Mitral Stenosis Treatment Overview

Jump to navigation Jump to search

WikiDoc Resources for Mitral Stenosis Treatment Overview

Articles

Most recent articles on Mitral Stenosis Treatment Overview

Most cited articles on Mitral Stenosis Treatment Overview

Review articles on Mitral Stenosis Treatment Overview

Articles on Mitral Stenosis Treatment Overview in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mitral Stenosis Treatment Overview

Images of Mitral Stenosis Treatment Overview

Photos of Mitral Stenosis Treatment Overview

Podcasts & MP3s on Mitral Stenosis Treatment Overview

Videos on Mitral Stenosis Treatment Overview

Evidence Based Medicine

Cochrane Collaboration on Mitral Stenosis Treatment Overview

Bandolier on Mitral Stenosis Treatment Overview

TRIP on Mitral Stenosis Treatment Overview

Clinical Trials

Ongoing Trials on Mitral Stenosis Treatment Overview at Clinical Trials.gov

Trial results on Mitral Stenosis Treatment Overview

Clinical Trials on Mitral Stenosis Treatment Overview at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mitral Stenosis Treatment Overview

NICE Guidance on Mitral Stenosis Treatment Overview

NHS PRODIGY Guidance

FDA on Mitral Stenosis Treatment Overview

CDC on Mitral Stenosis Treatment Overview

Books

Books on Mitral Stenosis Treatment Overview

News

Mitral Stenosis Treatment Overview in the news

Be alerted to news on Mitral Stenosis Treatment Overview

News trends on Mitral Stenosis Treatment Overview

Commentary

Blogs on Mitral Stenosis Treatment Overview

Definitions

Definitions of Mitral Stenosis Treatment Overview

Patient Resources / Community

Patient resources on Mitral Stenosis Treatment Overview

Discussion groups on Mitral Stenosis Treatment Overview

Patient Handouts on Mitral Stenosis Treatment Overview

Directions to Hospitals Treating Mitral Stenosis Treatment Overview

Risk calculators and risk factors for Mitral Stenosis Treatment Overview

Healthcare Provider Resources

Symptoms of Mitral Stenosis Treatment Overview

Causes & Risk Factors for Mitral Stenosis Treatment Overview

Diagnostic studies for Mitral Stenosis Treatment Overview

Treatment of Mitral Stenosis Treatment Overview

Continuing Medical Education (CME)

CME Programs on Mitral Stenosis Treatment Overview

International

Mitral Stenosis Treatment Overview en Espanol

Mitral Stenosis Treatment Overview en Francais

Business

Mitral Stenosis Treatment Overview in the Marketplace

Patents on Mitral Stenosis Treatment Overview

Experimental / Informatics

List of terms related to Mitral Stenosis Treatment Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

The choice of treatment depends on the symptoms present and the condition and function of the heart. Patients with high blood pressure or a weakened heart muscle may be given medications to reduce the strain on the heart and help improve the condition.

Anticoagulant or antiplatelet medications (blood thinners) may be used to prevent clots from forming in patients with atrial fibrillation. The 2006 ACC/AHA guidelines on the management of valvular heart disease recommended long-term oral anticoagulation in patients with mitral stenosis who have a prior embolic event, left atrial thrombus, or atrial fibrillation [1][2].

Digitalis may be used to strengthen the heartbeat, along with diuretics (water pills) to remove excess fluid in the lungs.

A low-sodium diet may be helpful. Most people have no symptoms; but if a person develops symptoms, activity may be restricted.

Cases of mild mitral stenosis (mitral valve area >1.5 cm2) can be followed up yearly with history, physical examination, EKG and some imaging studies like echocardiography.

The 2006 American College of Cardiology/American Heart Association (ACC/AHA) guidelines for management of valvular heart disease recommended routine repeat echocardiography every year for patients with severe mitral stenosis, every one to two years for patients with moderate mitral stenosis and every three to five years for patients with mild mitral stenosis [3]. By echocardiography, the doctor can assess the pulmonary artery pressure to decide if the surgery is indicated for the patient with mitral stenosis or not.

Hospitalization may be required for diagnosis and treatment of severe symptoms. Surgical repair or replacement of the valve is recommended if heart function is poor, symptoms are severe, or the condition gets worse. Medical therapy can relieve symptoms, but the patient may need surgery to relieve the blood flow obstruction by mitral stenosis. Some studies showed that surgical treatment reduces the overall mortality rate of mitral stenosis compared to medical treatment [4][5][6].

Pharmacotherapy

  • In asymptomatic patients, use endocarditis prophylaxis and chronic anticoagulation for intermittent or chronic atrial fibrillation, systemic embolism and marked LA enlargement (>55mm).
  • In symptomatic patients, control heartrate and Maintain NSR (normal sinus rhythm) (digoxin, antiarrhythmic agents) and B-blockers. Use diuretics for control of pulmonary edema. The decision of whether to proceed with vavluloplasty or surgical commissurotomy depends on the severity of symptoms and/or severe (>50mm Hg) PHTN. Relative indications would be for Class II, III symptoms, episodic pulmonary edema, prevention of thromboembolism, or moderate (45-50mm Hg) PHTN. The decision of whether valvuloplasty is superior to surgery depends on age (<60 favors valvuloplasty), and Cath/ECHO findings (e.g. LVEDP, degree of mobility, thickening and calcification). The average end result with both strategies is about 2 cm2. Moderate or greater MR (mitral regurgitation) and LA thrombus are contraindications to valvuloplasty.

References

  1. Salem DN, O'Gara PT, Madias C, Pauker SG, American College of Chest Physicians (2008). "Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)". Chest. 133 (6 Suppl): 593S–629S. doi:10.1378/chest.08-0724. PMID 18574274.
  2. Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL; et al. (2008). "Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)". Chest. 133 (6 Suppl): 546S–592S. doi:10.1378/chest.08-0678. PMID 18574273.
  3. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD; et al. (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172.
  4. ROWE JC, BLAND EF, SPRAGUE HB, WHITE PD (1960). "The course of mitral stenosis without surgery: ten- and twenty-year perspectives". Ann Intern Med. 52: 741–9. PMID 14439687.
  5. Dahl JC, Winchell P, Borden CW (1967). "Mitral stenosis. A long term postoperative follow-up". Arch Intern Med. 119 (1): 92–7. PMID 6015840.
  6. Roy SB, Gopinath N (1968). "Mitral stenosis". Circulation. 38 (1 Suppl): 68–76. PMID 4889600.

Template:WikiDoc Sources